Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
Jianjun RenWendu PangKatrina HuenikenGhazal HaddadAndrew HopeShao Hui HuangAnna SpreaficoAaron Richard HansenBayardo Perez-OrdonezDavid P GoldsteinScott V BratmanWei ZhangYu ZhaoWei XuJohn R De AlmeidaGeoffrey LiuPublished in: Cancer (2021)
This study indicates that the long-term health utility and symptoms/toxicities of patients with the most common head and neck cancers (ie, squamous cell carcinomas and nasopharyngeal carcinomas) differ over time with a variety of factors, including the tumor anatomic site, treatment volume, clinicodemographic characteristics (eg, age, human papillomavirus status, tumor stage, gender, smoking status, alcohol status, education, and comorbidities), and treatment modalities. Generalizations across all head and neck cancers should be strongly discouraged. Future studies should evaluate health utility, symptoms and toxicities, and patient need assessments separately for each anatomic site and treatment modality.